奈米醫材 (6612) 月營收分析比較圖

奈米醫材 (6612) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2024/11	97,571	44,611	14.9%	118.7%	785,411	569,478	37.9%
2024/10	84,947	58,792	6%	44.5%	687,840	524,867	31%
2024/09	80,138	52,407	-18%	52.9%	602,893	466,075	29.4%
2024/08	97,785	53,272	23.7%	83.6%	522,755	413,669	26.4%
2024/07	79,030	54,002	14.2%	46.3%	424,970	360,396	17.9%
2024/06	69,173	46,245	20.3%	49.6%	345,940	306,394	12.9%
2024/05	57,506	57,702	-1.3%	-0.3%	276,767	260,149	6.4%
2024/04	58,260	54,039	-14.7%	7.8%	219,261	202,447	8.3%
2024/03	68,280	59,866	42.1%	14.1%	161,001	148,407	8.5%
2024/02	48,036	51,113	7.5%	-6%	92,721	88,542	4.7%
2024/01	44,685	37,428	23.7%	19.4%	44,685	37,428	19.4%
2023/12	36,132	52,281	-19%	-30.9%	605,610	513,098	18%
2023/11	44,611	38,329	-24.1%	16.4%	569,478	460,817	23.6%
2023/10	58,792	48,150	12.2%	22.1%	524,867	422,488	24.2%
2023/09	52,407	34,679	-1.6%	51.1%	466,075	374,338	24.5%
2023/08	53,272	49,978	-1.4%	6.6%	413,669	339,659	21.8%
2023/07	54,002	46,314	16.8%	16.6%	360,396	289,680	24.4%
2023/06	46,245	40,046	-19.9%	15.5%	306,394	243,367	25.9%
2023/05	57,702	46,315	6.8%	24.6%	260,149	203,321	27.9%
2023/04	54,039	37,882	-9.7%	42.7%	202,447	157,006	28.9%
2023/03	59,866	44,945	17.1%	33.2%	148,407	119,124	24.6%
2023/02	51,113	43,562	36.6%	17.3%	88,542	74,179	19.4%
2023/01	37,428	30,617	-28.4%	22.2%	37,428	30,617	22.2%
2022/12	52,281	40,698	36.4%	28.5%	513,098	393,921	30.3%
2022/11	38,329	36,241	-20.4%	5.8%	460,817	353,223	30.5%
2022/10	48,150	36,135	38.8%	33.3%	422,488	316,982	33.3%
2022/09	34,679	32,677	-30.6%	6.1%	374,338	280,848	33.3%
2022/08	49,978	34,520	7.9%	44.8%	339,659	248,171	36.9%
2022/07	46,314	34,214	15.6%	35.4%	289,680	213,651	35.6%
2022/06	40,046	31,970	-13.5%	25.3%	243,367	179,436	35.6%
2022/05	46,315	30,630	22.3%	51.2%	203,321	147,466	37.9%
2022/04	37,882	32,879	-15.7%	15.2%	157,006	116,836	34.4%
2022/03	44,945	30,030	3.2%	49.7%	119,124	83,957	41.9%
2022/02	43,562	28,488	42.3%	52.9%	74,179	53,927	37.5%
2022/01	30,617	25,438	-24.8%	20.4%	30,617	25,438	20.4%
2021/12	40,698	19,073	12.3%	113.4%	393,921	362,760	8.6%